Table 1.

Pediatric unrelated cord blood transplant results


Investigator

No. patients

Diseases

Median follow-up time, mo

Disease-free survival, %
Kurtzberg et al33   25   ALL, AML, MDS, Fanconi, metabolic, other   13   48  
Locatelli et al31   60   ALL, AML   14   34  
Gluckman et al40   65*  ALL, AML, MDS, CML, lymphoma, Fanconi, metabolic disorders, other   10   29  
Wagner et al36   102   AML, ALL, CML, lymphoma, Fanconi, metabolic disorders, other   32   47  
Michel et al35   95   AML   31   41  
Staba et al39 
 
20
 
Hurler syndrome
 
30
 
85
 

Investigator

No. patients

Diseases

Median follow-up time, mo

Disease-free survival, %
Kurtzberg et al33   25   ALL, AML, MDS, Fanconi, metabolic, other   13   48  
Locatelli et al31   60   ALL, AML   14   34  
Gluckman et al40   65*  ALL, AML, MDS, CML, lymphoma, Fanconi, metabolic disorders, other   10   29  
Wagner et al36   102   AML, ALL, CML, lymphoma, Fanconi, metabolic disorders, other   32   47  
Michel et al35   95   AML   31   41  
Staba et al39 
 
20
 
Hurler syndrome
 
30
 
85
 

ALL indicates acute lymphocytic leukemia; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia.

*

20 patients under age 20

Close Modal

or Create an Account

Close Modal
Close Modal